Cytology and HPV Testing Market Global Growth, Opportunities, Industry Analysis & Forecast to 2025

New York, October 21, 2020: The Cytology and HPV testing market is expected to exceed more than USD 10 Billion by 2024. HPV testing market will grow at a CAGR of more than 10% in the given forecast period. While Cytology testing market will grow at a CAGR of around 5% from 2016 to 2024.

FYI, you will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/cytology-and-hpv-testing-market-report

Cytology also called as cell biology and cytopathology in which study of cell composition, cell structure and the interaction among cells and the environment in which they exist. It also examines the cell structure which helps to diagnose disease. Human papilloma virus (HPV) is group of more than 100 related viruses. They can affect the moist membranes of body part such as anus, vagina, vulva and lining of the mouth and throat. It also affects the skin of human body, trachea, bronchi, inner nose, mouth and inner eyelids. All human papilloma viruses (HPV) in the group are specified a number called an HPV type. The implication of early diagnosis and detection is not lost on them resultant in the improved adoption of these tests such as cytology and HPV testing.

The Major Driving factors of cytology and HPV testing market are as follows:

Growing cervical cancer screening awareness plans
High occurrence rate of HPV infections
Increasing the amount of cervical cancer globally

The Restraining factors of Cytology and HPV testing market are as follows:

Low understanding of the global population
Need of correct primary healthcare infrastructure

The cytology and HPV testing market is segmented on the lines of its product, service and by geography. Based on product and service segmentation the cytology and HPV testing market covers HPV testing and cytology testing. HPV testing is further segmented into services, assay kits and system. Based on cytology testing segment the market covers services, assay kits and system. The cytology and HPV testing market covers the  geographic segmentation in various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for cytology and HPV testing and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2021.
3) Identifications of new market opportunities and targeted promotional plans for cytology and HPV testing market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of cytology and HPV testing market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN N.V., and OncoHealth Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Cytology and HPV testing Market has been segmented as below:  

The Cytology and HPV testing Market is Segmented on the lines of Product and Services Analysis and Regional Analysis. By Product and Services Analysis this market is segmented on the basis of HPV Testing its covers Services, Assay kits and System. Cytology Testing its covers Services, Assay kits and System.

By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

Request Sample Report: https://www.marketresearchengine.com/reportdetails/cytology-and-hpv-testing-market-report

Table of Contents

Chapter 1 INTRODUCTION

hapter 2 Executive Summary

2.1 Global Cytology and HPV Testing Market, Estimates and Forecast, By Revenue, 2014–2024 (US$ Mn)
2.2 Global HPV Testing Market, by Product and Services, 2015 (US$ Mn)
2.3 Global Cytology Testing Market, by Product and Services, 2015 (US$ Mn)
2.4 Global Market Share by Geography, 2015 and 2024 (Value %)
2.5 Cytology and HPV Testing Market Snapshot

Chapter 3 Cytology and HPV Testing Market – Market Analysis

Chapter 4 Market Segmentation – By Region

Chapter 5 Company Profiles

5.1 Abbott Laboratories, Inc.

5.1.1 Company Overview

5.1.2 Financial Overview

5.1.3 Product Portfolio

5.1.4  Business Strategies

5.1.5  Recent Development

5.2 Arbor Vita Corporation

5.3 Becton, Dickinson and Company

5.4 Cepheid, Inc.

5.5 F. Hoffmann-La Roche Ltd.

5.6 Fujirebio Diagnostics, Inc.

5.7 Hologic, Inc.

5.8 OncoHealth Corporation

5.9 QIAGEN N.V

Other Related Market Research Reports:

Cell Counting Devices Market to hit more than US$ 10 Billion By 2022

Cord Stem Cell Banking Market is Expected to Grow US$ 4 Billion By 2022

Deception Technology Market to Perceive Substantial Growth During 2022

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/